Overall, therefore, the main effects of GLP-1 are a reduction of fasting and postprandial blood glucose levels, lowering of body weight and protection from CVD, which are all therapeutic targets in type 2 diabetes (Fig. 2). The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.